Stay Updated

News & Reports

For all press requests, please reach out to press@p4adnow.org.

News and Reports

The Hill: Appeals court upholds dismissal of US Chamber challenge to Medicare negotiation

The advocacy group Patients For Affordable Drugs applauded the ruling. “This decision marks the 10th court ruling in favor of patients and against the pharmaceutical industry’s desperate legal attacks on the overwhelmingly popular Medicare Negotiation Program, which in January will deliver lower prices to more than 9 million patients across the nation,” Merith Basey, the […]

News and Reports

Global Genes: ORPHAN Cures Act Removed from Senate Budget Reconciliation Bill

While industry groups and rare disease patient advocacy organizations, such as the Biotechnology Innovation Organization and National Organization for Rare Disorders, support passage of the ORPHAN Cures Act, other groups, such as Public Citizen, AARP, and Patients for Affordable Drugs Now, have opposed it. “This decision helps protect the popular and effective Medicare Drug Price […]

News and Reports

Fierce Pharma: In setback for biopharma, Senate version of Trump's tax bill drops Orphan Cures Act

For its part, the Patients For Affordable Drugs Now (P4ADNOW), an organization focused on lowering drug prices, touted the exclusion of the Orphan Cures Act from the Senate’s reconciliation text as a “direct rejection of the pharmaceutical industry’s greed-driven agenda.” “This decision helps protect the popular and effective Medicare negotiation program and its promise of […]

News and Reports

Axios Pro: Megabill has little-noticed drug pricing changes

Merith Basey, executive director of Patients for Affordable Drugs, countered that the measure is “simply put, a giveaway to pharma.” “Americans are asking Congress to do more to lower drug prices, and believe that drug prices are far too high,” she added. “This is going exactly in the opposite direction that voters are demanding.”